Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1544227 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.89Day +2.46%Mkt cap $13M1Y −87.7%Off 52W high −92.7%Vol (1Y) 102.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,271 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest2.1% of sh out |
| Days to cover2.0d |
| 13F net flow (QoQ)−0.87% |
| Top-10 13F concentration99.1% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$43.1M |
| ROE−203.6% |
| Debt / equity0.00× |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−68.9% |
| 1Y−87.7% |
| 3Y−92.9% |
| 5Y−99.6% |
| Since incept. (ann.)−64.1% |
Total return through 2026-07-29 · series begins 2021-06-29. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)102.7% |
| Ann. volatility (3Y)2309.7% |
| Sharpe (1Y)−1.61 |
| Sharpe (3Y)0.52 |
| Max drawdown (1Y)−92.6% |
| Max drawdown (3Y)−99.3% |
| Beta (3Y vs SPY)−6.49 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Versant Venture Management, LLC | 269,772 | $442,426 | 1.82% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 233,888 | $383,576 | 1.58% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 86,990 | $142,666 | 0.59% | +97.2% |
| VANGUARD FIDUCIARY TRUST CO | 68,908 | $113,009 | 0.47% | new |
| BlackRock, Inc. | 39,068 | $64,072 | 0.26% | +0.0% |
| FMR LLC | 33,225 | $54,489 | 0.22% | +0.0% |
| SABBY MANAGEMENT, LLC | 17,856 | $29,284 | 0.12% | −90.0% |
| NORTHERN TRUST CORP | 14,053 | $23,047 | 0.09% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$2.53 | — | — | — |
| 2025-09-30 | 2025-11-05 | −$0.79 | — | — | — |
| 2025-06-30 | 2025-08-11 | −$2.07 | — | — | — |
| 2025-03-31 | 2025-05-13 | −$3.16 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 90d) — not company-confirmed.
